DK1129191T3 - Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme - Google Patents
Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdommeInfo
- Publication number
- DK1129191T3 DK1129191T3 DK99960975T DK99960975T DK1129191T3 DK 1129191 T3 DK1129191 T3 DK 1129191T3 DK 99960975 T DK99960975 T DK 99960975T DK 99960975 T DK99960975 T DK 99960975T DK 1129191 T3 DK1129191 T3 DK 1129191T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosing
- methods
- neurological diseases
- treating neurological
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Psychology (AREA)
- General Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98121478A EP1002862A1 (en) | 1998-11-12 | 1998-11-12 | Methods of diagnosing or treating neurological diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1129191T3 true DK1129191T3 (da) | 2006-07-17 |
Family
ID=8232965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99960975T DK1129191T3 (da) | 1998-11-12 | 1999-11-12 | Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme |
Country Status (8)
Country | Link |
---|---|
US (2) | US20050239169A1 (da) |
EP (2) | EP1002862A1 (da) |
JP (1) | JP4663121B2 (da) |
AT (1) | ATE321135T1 (da) |
DE (1) | DE69930545T2 (da) |
DK (1) | DK1129191T3 (da) |
ES (1) | ES2262352T3 (da) |
WO (1) | WO2000029569A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000012525A1 (en) * | 1998-08-27 | 2000-03-09 | Quark Biotech, Inc. | Sequences characteristic of hypoxia-regulated gene transcription |
AU2002236503C1 (en) * | 2000-11-28 | 2008-11-13 | Wyeth | Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
US20050059001A1 (en) * | 2001-05-31 | 2005-03-17 | Akira Nakagawara | Nucleic acids isolated in neuroblastoma |
US20030068636A1 (en) | 2001-06-21 | 2003-04-10 | Millennium Pharmaceuticals, Inc. | Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
US20060099585A1 (en) * | 2002-05-28 | 2006-05-11 | Evoctec Neurosciences Gmbh | Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases |
EP2298807A3 (en) | 2004-07-30 | 2011-05-18 | Rinat Neuroscience Corp. | Antibodies directed against amyloid-beta peptide and methods using same |
UY29504A1 (es) | 2005-04-29 | 2006-10-31 | Rinat Neuroscience Corp | Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos. |
CN111788126B (zh) * | 2018-04-13 | 2022-03-04 | 株式会社胜一 | 可解除过压的喷射容器及其阀门组件 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0814157A3 (en) * | 1996-06-18 | 1998-01-07 | Smithkline Beecham Corporation | Diagnostic marker for variants of presenilin genes associated with Alzheimers Disease and Familial Adult Onset Alzheimers Disease |
WO2000012525A1 (en) * | 1998-08-27 | 2000-03-09 | Quark Biotech, Inc. | Sequences characteristic of hypoxia-regulated gene transcription |
-
1998
- 1998-11-12 EP EP98121478A patent/EP1002862A1/en not_active Withdrawn
-
1999
- 1999-11-12 WO PCT/EP1999/008744 patent/WO2000029569A1/en active IP Right Grant
- 1999-11-12 JP JP2000582553A patent/JP4663121B2/ja not_active Expired - Lifetime
- 1999-11-12 ES ES99960975T patent/ES2262352T3/es not_active Expired - Lifetime
- 1999-11-12 EP EP99960975A patent/EP1129191B1/en not_active Expired - Lifetime
- 1999-11-12 AT AT99960975T patent/ATE321135T1/de active
- 1999-11-12 DK DK99960975T patent/DK1129191T3/da active
- 1999-11-12 DE DE69930545T patent/DE69930545T2/de not_active Expired - Lifetime
-
2004
- 2004-08-04 US US10/910,772 patent/US20050239169A1/en not_active Abandoned
-
2007
- 2007-12-11 US US12/000,307 patent/US20080261302A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000029569A1 (en) | 2000-05-25 |
EP1129191A1 (en) | 2001-09-05 |
JP2002530076A (ja) | 2002-09-17 |
ATE321135T1 (de) | 2006-04-15 |
US20080261302A1 (en) | 2008-10-23 |
US20050239169A1 (en) | 2005-10-27 |
DE69930545T2 (de) | 2007-03-08 |
DE69930545D1 (de) | 2006-05-11 |
EP1002862A1 (en) | 2000-05-24 |
ES2262352T3 (es) | 2006-11-16 |
JP4663121B2 (ja) | 2011-03-30 |
EP1129191B1 (en) | 2006-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69636495D1 (de) | Multi-tumor abweichende wachstumsgene | |
CY1106978T1 (el) | Ενζυμα φωσφοδιεστερασης | |
BR9912455A (pt) | ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória | |
ES545725A0 (es) | Procedimiento para preparar peptidos de interferon | |
DK2256205T3 (da) | Porphorymonas gingivalis-polypeptider og -polynukleotider | |
DK0920501T3 (da) | Neuritin, et neurogen | |
DK1129191T3 (da) | Fremgangsmåder til diagnosticering eller behandling af neurologiske sygdomme | |
ATE223491T1 (de) | Verfahren zur reinigung von biomolekül- oder proteinkomplexen | |
DK1108786T3 (da) | Hidtil ukendt kollektin | |
DE69739071D1 (de) | Menschliche tak1 und für diese kodierende dna | |
DK0923644T3 (da) | G-koblet receptor, der udviser selektiv selektivitet for ATP | |
NO942443L (no) | Gen kodende for kationisk aminosyre transporter protein | |
EP0816498A3 (en) | Excitatory amino acid receptor protein and related nucleic acid compounds | |
EP0911408A3 (en) | DNA coding for serine/threonine kinase | |
DE69731682D1 (de) | TAB1 Protein und dafür kodierende DNA | |
EE200100234A (et) | PRV-1-geen ja selle kasutamine | |
ATE304553T1 (de) | Polypeptide mit wasserkanalaktivität und dna sequenzen | |
FR2757524B1 (fr) | Polypeptides de la famille bhlh, sequences d'acides nucleiques correspondantes | |
DE69943149D1 (en) | Serinprotease bssp2 | |
WO2003060074A3 (en) | Novel metastasis suppressor gene on human chromosome 8 | |
BR0107799A (pt) | Proteìna de interação de wt1 wtip |